Primo Chemicals Ltd Upgraded to Buy on Improved Technicals and Financial Performance

Technical Trends Signal Renewed Momentum

The upgrade in Primo Chemicals’ rating is largely attributable to a shift in its technical grade from mildly bullish to bullish. Key technical indicators reveal a nuanced but overall positive picture. On a weekly basis, the Moving Average Convergence Divergence (MACD) remains mildly bearish, but the monthly MACD has turned mildly bullish, signalling a potential upward momentum in the medium term.

Further supporting this outlook, Bollinger Bands readings are bullish on both weekly and monthly charts, suggesting increased price volatility with an upward bias. Daily moving averages also confirm a bullish trend, reinforcing the short-term strength in the stock’s price action. The On-Balance Volume (OBV) indicator, which measures buying and selling pressure, is bullish on both weekly and monthly timeframes, indicating strong accumulation by investors.

Other technical tools present a mixed view: the Know Sure Thing (KST) indicator is mildly bearish weekly but mildly bullish monthly, while Dow Theory readings are mildly bullish weekly but mildly bearish monthly. The Relative Strength Index (RSI) shows no clear signal on either timeframe, suggesting the stock is not currently overbought or oversold.

This technical improvement is reflected in the stock’s recent price action. The current price stands at ₹25.27, up from a previous close of ₹22.39, marking a significant intraday gain of 12.86%. The stock has traded within a 52-week range of ₹16.21 to ₹27.50, with today’s high reaching ₹25.48. Such price strength, combined with positive technical signals, has been a key driver behind the rating upgrade.

Valuation Shifts to Expensive Amidst Strong Price Gains

While technicals have improved, Primo Chemicals’ valuation grade has shifted from fair to expensive. The company currently trades at a price-to-earnings (PE) ratio of 37.91, which is higher than many of its peers in the commodity chemicals sector. For comparison, J.G. Chemicals trades at a PE of 32.35 with a fair valuation grade, while Titan Biotech, another peer, is classified as very expensive with a PE of 48.29.

Other valuation metrics reinforce this elevated pricing. The enterprise value to EBITDA ratio stands at 10.76, and the enterprise value to EBIT ratio is notably high at 46.95. Price-to-book value is moderate at 1.51, but return on capital employed (ROCE) and return on equity (ROE) remain low at 2.95% and 3.83% respectively, suggesting limited efficiency in generating returns relative to the valuation premium.

Despite the expensive valuation, the stock’s recent price appreciation and technical momentum have justified the upgrade. Investors should, however, be mindful of the stretched multiples relative to the company’s modest profitability metrics.

Financial Trend Shows Positive Quarterly Momentum but Long-Term Challenges

Primo Chemicals has demonstrated a very positive financial performance in the first quarter of FY26-27, which has contributed to the upgrade. Operating profit grew by 5.59% in the quarter ended June 2026, marking the second consecutive quarter of positive results. Profit before tax excluding other income (PBT less OI) surged by an impressive 619.0% compared to the previous four-quarter average, reaching ₹3.62 crores.

The company’s debt-equity ratio remains low at 0.32 times, indicating a conservative capital structure. Additionally, the operating profit to interest coverage ratio is strong at 5.64 times, reflecting healthy earnings relative to interest expenses.

However, long-term financial trends present a more cautious picture. Net sales have declined at an annualised rate of -0.22% over the past five years, while operating profit has contracted by -39.61% annually during the same period. Over the past year, profits have fallen by -14.5%, and the stock’s one-year return is a marginal 0.08%, underperforming the Sensex, which declined by 8.95% over the same timeframe.

These mixed financial signals suggest that while recent quarters have shown improvement, the company faces challenges in sustaining long-term growth and profitability.

Stock Performance Compared to Sensex and Peers

Primo Chemicals’ stock has outperformed the Sensex in the short term, with a one-week return of 18.31% versus the Sensex’s -0.54%, and a one-month return of 21.20% compared to the Sensex’s -4.84%. Year-to-date, the stock has gained 5.51%, while the Sensex is down 13.29%. Over longer horizons, however, the stock has lagged significantly, with a three-year return of -57.39% against the Sensex’s 11.92% and a five-year return of -0.12% versus the Sensex’s 23.06%.

Notably, over a ten-year period, Primo Chemicals has delivered a remarkable 672.78% return, far outpacing the Sensex’s 157.76%. This highlights the stock’s potential for long-term wealth creation despite recent volatility and valuation concerns.

Quality Assessment and Shareholding Structure

Primo Chemicals is classified as a micro-cap company within the commodity chemicals sector. Its Mojo Score stands at 71.0, reflecting a Buy rating, upgraded from a previous Hold grade on 25 September 2026. The company’s quality metrics have remained stable, supported by its recent financial improvements and conservative debt levels.

The majority of shares are held by non-institutional investors, which can imply a more retail-driven ownership base. This may contribute to higher volatility but also indicates strong interest from individual shareholders.

Risks and Considerations for Investors

Despite the upgrade, investors should be cautious of several risks. The company’s long-term growth trajectory remains uncertain, with declining sales and operating profits over the past five years. The low returns on capital employed and equity raise questions about operational efficiency and profitability sustainability.

Valuation remains a concern, as the stock trades at a premium relative to many peers despite modest financial returns. Additionally, the stock’s recent price gains have been driven largely by technical factors and short-term financial improvements, which may not be sustainable without a broader turnaround in fundamentals.

Investors should weigh these factors carefully and consider the stock’s micro-cap status, which can entail higher liquidity risk and price volatility.

Conclusion: A Balanced Upgrade Reflecting Technical Strength and Recent Financial Gains

The upgrade of Primo Chemicals Ltd from Hold to Buy reflects a combination of improved technical indicators, positive quarterly financial results, and short-term price momentum. While valuation metrics have become more expensive and long-term growth challenges persist, the company’s recent performance and bullish technical signals have prompted a more favourable investment stance.

For investors seeking exposure to the commodity chemicals sector, Primo Chemicals offers an intriguing opportunity supported by strong technical momentum and improving financial trends. However, the elevated valuation and mixed long-term fundamentals warrant a cautious approach, with close monitoring of upcoming quarterly results and market developments.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →